BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,376,255 | -31.0% | 115,958 | -16.7% | 0.03% | -29.8% |
| Q2 2023 | $6,340,904 | +124770.1% | 139,177 | +11.2% | 0.05% | +17.5% |
| Q1 2023 | $5,078 | -28.7% | 125,199 | -10.4% | 0.04% | -28.6% |
| Q4 2022 | $7,120 | -99.9% | 139,683 | +3.1% | 0.06% | -9.7% |
| Q3 2022 | $7,322,000 | -16.5% | 135,452 | -0.8% | 0.06% | -19.5% |
| Q2 2022 | $8,772,000 | -10.5% | 136,566 | +8.0% | 0.08% | +11.6% |
| Q1 2022 | $9,802,000 | -27.9% | 126,416 | -25.2% | 0.07% | -15.9% |
| Q3 2021 | $13,596,000 | -9.5% | 169,038 | -9.4% | 0.08% | -12.8% |
| Q2 2021 | $15,024,000 | -8.2% | 186,629 | -3.8% | 0.09% | -9.6% |
| Q1 2021 | $16,361,000 | +1.2% | 193,991 | -3.7% | 0.10% | 0.0% |
| Q4 2020 | $16,168,000 | +5.0% | 201,491 | +5.2% | 0.10% | -16.1% |
| Q3 2020 | $15,399,000 | -22.2% | 191,482 | -16.7% | 0.12% | -31.9% |
| Q2 2020 | $19,791,000 | -0.0% | 229,860 | -5.7% | 0.18% | -17.3% |
| Q1 2020 | $19,800,000 | -5.6% | 243,874 | -2.8% | 0.22% | +22.2% |
| Q4 2019 | $20,978,000 | +10.3% | 250,874 | +15.4% | 0.18% | +6.5% |
| Q3 2019 | $19,020,000 | +6.7% | 217,441 | -0.1% | 0.17% | 0.0% |
| Q2 2019 | $17,832,000 | -7.5% | 217,735 | -8.1% | 0.17% | -10.1% |
| Q1 2019 | $19,272,000 | +28.2% | 237,015 | +3.8% | 0.19% | +12.6% |
| Q4 2018 | $15,031,000 | -13.9% | 228,370 | +0.8% | 0.17% | +5.0% |
| Q3 2018 | $17,466,000 | +27.7% | 226,570 | +22.3% | 0.16% | +12.8% |
| Q2 2018 | $13,682,000 | +12.1% | 185,299 | -0.5% | 0.14% | +11.0% |
| Q1 2018 | $12,202,000 | +11.5% | 186,263 | +10.0% | 0.13% | +12.4% |
| Q4 2017 | $10,948,000 | -2.0% | 169,363 | -4.8% | 0.11% | -10.3% |
| Q3 2017 | $11,168,000 | +4.2% | 177,970 | +0.2% | 0.13% | 0.0% |
| Q2 2017 | $10,720,000 | +18.6% | 177,695 | +2.0% | 0.13% | +17.8% |
| Q1 2017 | $9,036,000 | +17.3% | 174,245 | +0.3% | 0.11% | +13.8% |
| Q4 2016 | $7,702,000 | -8.8% | 173,713 | -2.1% | 0.09% | -13.8% |
| Q3 2016 | $8,447,000 | +4.0% | 177,468 | -1.2% | 0.11% | 0.0% |
| Q2 2016 | $8,125,000 | +15.3% | 179,668 | +4.7% | 0.11% | +7.9% |
| Q1 2016 | $7,046,000 | +35.9% | 171,521 | +26.2% | 0.10% | +36.5% |
| Q4 2015 | $5,185,000 | +11.3% | 135,921 | -2.4% | 0.07% | +4.2% |
| Q3 2015 | $4,658,000 | -59.5% | 139,221 | -15.3% | 0.07% | -56.4% |
| Q2 2015 | $11,498,000 | +10.0% | 164,421 | +7.8% | 0.16% | +13.2% |
| Q1 2015 | $10,448,000 | -1.9% | 152,521 | +4.9% | 0.14% | -1.4% |
| Q4 2014 | $10,654,000 | -14.3% | 145,371 | -16.0% | 0.15% | -16.1% |
| Q3 2014 | $12,427,000 | -1.3% | 173,152 | -0.6% | 0.17% | -0.6% |
| Q2 2014 | $12,591,000 | -3.6% | 174,152 | -1.9% | 0.18% | -5.4% |
| Q1 2014 | $13,058,000 | +1.5% | 177,468 | -4.1% | 0.18% | +0.5% |
| Q4 2013 | $12,869,000 | -2.0% | 185,036 | -7.4% | 0.18% | -8.5% |
| Q3 2013 | $13,133,000 | -15.5% | 199,925 | -10.9% | 0.20% | -16.6% |
| Q2 2013 | $15,551,000 | – | 224,496 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |